T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1γ

Osteoarthritis and Cartilage

Volumn 19, Issue 6, 2011, Pages 728-736

  Shen, P C ^a   Wu, C L ^b   Jou, I M ^b   Lee, C H ^c   Juan, H Y ^b   Lee, P J ^b   Chen, S H ^b   Hsieh, J L ^d  

^a Tainan Hospital   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Anterior cruciate ligament; CD4+ t cells; MIP 1 ; Osteoarthritis; Osteoclast

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 1GAMMA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; HISTOLOGY; IMMUNOBLOTTING; IMMUNOCHEMISTRY; KNEE; KNEE OSTEOARTHRITIS; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; STAINING; SYNOVIUM;

ANIMALS; DISEASE PROGRESSION; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MACROPHAGE INFLAMMATORY PROTEINS; MICE; NF-KAPPA B; OSTEOARTHRITIS, KNEE; T-LYMPHOCYTES;

EID: 79955964710     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2011.02.014     Document Type: Article

References (30)

1. Pelletier J.P., Martel-Pelletier J., Howel D.S. Etiopathogenesis of osteoarthritis. Arthritis and Allied Conditions: a Textbook of Rheumatology 2000, 2195-2245. Williams & Wilkins, Baltimore. 14th edn. W.J. Koopman (Ed.).
2. Sowers M. Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 2001, 13:447-451.
3. Hsieh J.L., Shen P.C., Shiau A.L., Jou I.M., Lee C.H., Teo M.L., et al. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum Gene Ther 2009, 20:147-158.
4. Hsieh J.L., Shen P.C., Shiau A.L., Jou I.M., Lee C.H., Wang C.R., et al. Intraarticular gene transfer of thrombospondin-1 suppresses the disease progression of experimental osteoarthritis. J Orthop Res 2010, [Epub ahead of print].
5. Sakkas L.I., Platsoucas C.D. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum 2007, 56:409-424.
6. Wagner D.H., Stout R.D., Suttles J. Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis. Eur J Immunol 1994, 24:3148-3154.
7. Aarvak T., Chabaud M., Miossec P., Natvig J.B. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999, 162:1246-1251.
8. Nakashima T., Takayanagi H. Osteoimmunology: crosstalk between the immune and bone systems. J Clin Immunol 2009, 29:555-567.
9. Kamekura S., Hoshi K., Shimoaka T., Chung U., Chikuda H., Yamada T., et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005, 13:632-641.
10. Mankin H.J., Dorfman H., Lippiello L., Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971, 53:523-537.
11. Yoshimi T., Kikuchi T., Obara T., Yamaguchi T., Sakakibara Y., Itoh H., et al. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin Orthop Relat Res 1994, 298:296-304.
12. Engsig M.T., Chen Q.J., Vu T.H., Pedersen A.C., Therkidsen B., Lund L.R., et al. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 2000, 151:879-889.
13. Comabella M., Julià E., Tintoré M., Brieva L., Téllez N., Río J., et al. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon β-1b in patients with progressive multiple sclerosis. J Neurol 2008, 255:1136-1141.
14. Lee S.I., Jeong S.R., Kang Y.M., Han D.H., Jin B.K., Namgung U., et al. Endogenous expression of interleukin-4 regulates macrophage activation and confines cavity formation after traumatic spinal cord injury. J Neurosci Res 2010, 5(88):2409-2419.
15. Gomez D.E., Alonso D.F., Yoshiji H., Thorgeirsson U.P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997, 74:111-122.
16. Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004, 50:131-141.
17. Leonardi A., Cortivo R., Fregona I., Plebani M., Secchi A.G., Abatangelo G. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Invest Ophthalmol Vis Sci 2003, 44:183-189.
18. Mohamadzadeh M., Poltorak A.N., Bergstressor P.R., Beutler B., Takashima A. Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. J Immunol 1996, 156:3102-3106.
19. Poltorak A.N., Bazzoni F., Smirnova I.I., Alejos E., Thompson P., Luheshi G., et al. MIP-1 γ: molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J Inflamm 1995, 45:207-219.
20. Katrib A., Tak P.P., Bertouch J.V., Cuello C., McNeil H.P., Smeets T.J., et al. Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis. Rheumatology 2001, 40:988-994.
21. Robinson E., Keystone E.C., Schallf T.J., Gillettt N., Fish E.N. Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1, 3 p.oduction by synovial T cells. Clin Exp Immunol 1995, 101:398-407.
22. Okamatsu Y., Kim D., Battaglino R., Sasaki H., Späte U., Stashenko P. MIP-1 gamma promotes receptor-activator-of-NF-κ-B-ligand-induced osteoclast formation and survival. J Immunol 2004, 173:2084-2090.
23. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999, 402:304-309.
24. Lean J.M., Murphy C., Fuller K., Chambers T.J. CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 2002, 87:386-393.
25. Rho J., Takami M., Choi Y. Osteoimmunology: interactions of the immune and skeletal systems. Mol Cell 2004, 17:1-9.
26. Abu-Amer Y.J. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-kappa B. J Clin Invest 2001, 107:1375-1385.
27. Kotake S., Udagawa N., Takahashi N., Matsuzaki K., Itoh K., Ishiyama S., et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999, 103:1345-1352.
28. Kitami S., Tanaka H., Kawato T., Tanabe N., Katono-Tani T., Zhang F., et al. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie 2010, 92:398-404.
29. Qiu Z., Dillen C., Hu J., Verbeke H., Struyf S., Van Damme J., et al. Interleukin-17 regulates chemokine and gelatinase B expression in fibroblasts to recruit both neutrophils and monocytes. Immunology 2009, 214:835-842.
30. Tan L.C., Mowat A.G., Fazou C., Rostron T., Roskell H., Dunbar P.R., et al. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Rheum 2000, 2:154-164.